Kaushik Ivaturi

Kaushik Ivaturi practices at U.S. Renal Care Long Beach Dialysis in Long Beach, California.

Kaushik Ivaturi's NPI, 1669733275, was assigned on May 31, 2012. Kaushik Ivaturi graduated from Kamineni Institute of Medical Science in 2010. Kaushik Ivaturi holds California license A134126.

Kaushik Ivaturi's primary practice is U.S. Renal Care Long Beach Dialysis, at 3744 Long Beach Blvd, Long Beach, CA 90807 in Los Angeles County. The practice phone is (562) 435-3637.

Kaushik Ivaturi's primary practice is U.S. Renal Care Long Beach Dialysis in Long Beach, California. Kaushik Ivaturi is also affiliated with Long Beach Medical Center. The medical group on file is ProHealth Partners. Dmand AI also links Kaushik Ivaturi to 1 more hospital, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kaushik Ivaturi practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Kaushik Ivaturi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Kaushik Ivaturi is board certified in internal medicine by the American Board of Internal Medicine. Kaushik Ivaturi is licensed in California.

Dmand AI lists acute kidney failure, chronic diabetes, chronic hypertension, chronic kidney disease, congestive heart failure and sepsis among the conditions Kaushik Ivaturi treats.

CMS data shows 2,038 Medicare services from Kaushik Ivaturi across 9 procedure codes in 2024, for 442 Medicare patients. Medicare paid $241,964 for them.

CMS counts 442 Medicare patients who saw Kaushik Ivaturi in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 74% are also on Medicaid. Their average risk score is 5.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kaushik Ivaturi's median patient age at 62, with 40% women.

In 2024, Kaushik Ivaturi wrote 158 Medicare Part D claims for 38 patients. 66% of them were for generic drugs. CMS names the drug for 41 of them, across 3 drugs with 11 or more claims each, at $22,521 in total drug cost. In 2023, CMS named 46 claims across 3 drugs.

Kaushik Ivaturi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kaushik Ivaturi as offering telehealth.

Dmand AI links 2 papers to Kaushik Ivaturi, published from 2017 to 2021. Kaushik Ivaturi's most frequent co-authors are Antoney Joseph Ferrey, MD, Ramy Magdy Hanna, MD and Sanjivan Singh Kohli, MD.

CMS Open Payments shows 216 general payments to Kaushik Ivaturi from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Aurinia Pharma U.S., Inc. paid the most, $664.

Kaushik Ivaturi graduated from Kamineni Institute of Medical Science in 2010.

Kaushik Ivaturi is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.